Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1356 USD | +7.41% | +4.47% | -3.14% |
Financials (USD)
Sales 2022 | 32.26M | Sales 2023 | 34.16M | Capitalization | 29.4M |
---|---|---|---|---|---|
Net income 2022 | 8M | Net income 2023 | 3M | EV / Sales 2022 | 0.92 x |
Net cash position 2022 | 5.75M | Net cash position 2023 | 3.94M | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
4.73
x | P/E ratio 2023 |
9.34
x | Employees | 53 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.76% |
Latest transcript on Elite Pharmaceuticals, Inc.
1 day | +7.41% | ||
1 week | +4.47% | ||
Current month | +4.55% | ||
1 month | -3.14% | ||
3 months | -28.63% | ||
6 months | +17.91% | ||
Current year | -3.14% |
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 09-06-30 |
Christopher Dick
PSD | President | 69 | 02-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 09-10-22 |
Barry Dash
BRD | Director/Board Member | 93 | 05-03-31 |
Davis Caskey
BRD | Director/Board Member | 76 | 16-04-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.1356 | +7.41% | 1,112,478 |
24-05-09 | 0.1262 | -4.36% | 438,341 |
24-05-08 | 0.132 | -2.22% | 312,401 |
24-05-07 | 0.135 | -5.92% | 637,891 |
24-05-06 | 0.1435 | +10.55% | 1,345,735 |
Delayed Quote OTC Markets, May 10, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-3.14% | 145M | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- ELTP Stock